Artivion, Inc.
AORTNYSECIK 784199HealthcareFiscal year ends Dec 31
Reports and events: 322 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0713:57 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-054746 |
| 2026-08-0616:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-054294 |
| 2026-05-1807:06 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-035798 |
| 2026-05-1515:13 ET | 8-K | 5.07 Shareholder vote results | 0001628280-26-035507 |
| 2026-05-0810:56 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-032620 |
| 2026-05-0716:10 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-032097 |
| 2026-04-0116:18 ET | DEF 14A | Proxy statementPeriod 2026-05-12 | 0001999371-26-007510 |
| 2026-02-1816:14 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001628280-26-009046 |
| 2026-02-1216:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-007674 |
| 2025-11-0711:41 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001628280-25-050502 |
| 2025-11-0616:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-050164 |
| 2025-09-2916:26 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001628280-25-043099 |
| 2025-09-1507:58 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000784199-25-000145 |
| 2025-08-1216:23 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001214659-25-011863 |
| 2025-08-1113:18 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000784199-25-000136 |
| 2025-08-0811:30 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001628280-25-039166 |
| 2025-08-0716:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-038873 |
| 2025-05-2918:01 ET | 8-K | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0000784199-25-000129 |
| 2025-05-1614:32 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000784199-25-000083 |
| 2025-05-1416:05 ET | 8-K | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0000784199-25-000080 |
| 2025-05-0615:10 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000784199-25-000074 |
| 2025-05-0516:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000784199-25-000069 |
| 2025-04-0116:46 ET | DEF 14A | Proxy statementPeriod 2025-05-13 | 0001999371-25-003629 |
| 2025-02-2814:28 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000784199-25-000029 |
| 2025-02-2416:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000784199-25-000012 |
| 2024-12-2316:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000784199-24-000265 |
| 2024-12-0908:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000784199-24-000254 |
| 2024-12-0907:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000784199-24-000253 |
| 2024-11-0815:10 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000784199-24-000243 |
| 2024-11-0716:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000784199-24-000234 |
| 2024-08-0911:47 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000784199-24-000215 |
| 2024-08-0816:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000784199-24-000211 |
| 2024-07-0116:13 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000784199-24-000207 |
| 2024-05-1716:14 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000784199-24-000184 |
| 2024-05-1617:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results | 0000784199-24-000181 |
| 2024-05-0712:07 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000784199-24-000172 |
| 2024-05-0616:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000784199-24-000169 |
| 2024-04-0116:56 ET | DEF 14A | Proxy statementPeriod 2024-05-14 | 0001999371-24-004301 |
| 2024-02-2317:06 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000784199-24-000033 |
| 2024-02-1516:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000784199-24-000013 |
| 2024-01-1816:12 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950157-24-000061 |
| 2023-12-0616:23 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000784199-23-000155 |
| 2023-11-0314:56 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000784199-23-000150 |
| 2023-11-0216:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000784199-23-000146 |
| 2023-08-0816:17 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000784199-23-000139 |
| 2023-08-0415:00 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000784199-23-000134 |
| 2023-08-0316:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000784199-23-000130 |
| 2023-05-1912:26 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000784199-23-000092 |
| 2023-05-0514:56 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000784199-23-000088 |
| 2023-05-0416:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000784199-23-000084 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:31 ET. Listed shows no prices and gives no investment advice.